subject area of
- 5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis Journal Articles
- 5-Aminosalicylates for non-surgical patients with active or quiescent Crohn's disease: an overview of systematic reviews (umbrella review). Journal Articles
- A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group Conferences
- Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease Journal Articles
- Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials Journal Articles
- Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression Journal Articles
- Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis Journal Articles
- Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis Journal Articles
- Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis Journal Articles
- Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis Journal Articles
- Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission Conferences
- Interstitial Nephritis in Patients with Inflammatory Bowel Disease Treated with Mesalamine Journal Articles
- Ketotifen Treatment of Active Colitis in Patients with 5‐Aminosalicylate Intolerance Journal Articles
- Letter: mesalazine—a safe drug with rare serious adverse events? Authors’ reply Journal Articles
- Mesalamine (5-ASA) for the prevention of recurrent diverticulitis Journal Articles
- Mesalazine (5‐aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea‐predominant irritable bowel syndrome Journal Articles
- Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis Journal Articles
- Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis Journal Articles
- New Applications for Traditional Drugs in Inflammatory Bowel Disease Journal Articles
- Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis Journal Articles
- Oral budesonide for induction of remission in ulcerative colitis Journal Articles
- Oral budesonide for induction of remission in ulcerative colitis Journal Articles
- Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study Journal Articles
- Putting Rectal 5-Aminosalicylic Acid in Its Place: The Role in Distal Ulcerative Colitis Journal Articles
- Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis Journal Articles
- Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis Journal Articles
- Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Journal Articles
- Resource utilization during pediatric to adult transfer of care in IBD Journal Articles
- Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis Journal Articles
- Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis Journal Articles
- Systematic review: safety of mesalazine in ulcerative colitis Journal Articles
- Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial Journal Articles